Profile
BBLN GEHC VEEV GEHCV DOCS HQY
Company Name Babylon Holdings Limited GE HealthCare Technologies Inc. Veeva Systems Inc. GE HealthCare Technologies Inc. Doximity, Inc. HealthEquity, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Healthcare Information Services Medical - Healthcare Information Services Medical - Healthcare Information Services Medical - Healthcare Information Services Medical - Healthcare Information Services Medical - Healthcare Information Services
Market Cap $14.10M $38.56B $34.23B $25.46B $9.48B $8.98B
Employees 1.90K 51.00K 7.17K 51.00K 0.83K 3.13K
CEO Dr. Ali Parsadoust Mr. Peter J. Arduini Mr. Peter P. Gassner Mr. Peter J. Arduini Mr. Jeffrey A. Tangney Mr. Jon Kessler
Ratings
BBLN GEHC VEEV GEHCV DOCS HQY
Quant Rating Score 3 3 3 3
Quant Rating Neutral Neutral Neutral Neutral
Trading
BBLN GEHC VEEV GEHCV DOCS HQY
Last Close $0.5504 $84.13 $210.86 $56 $50.77 $103.61
High 52 $0.55 $93.87 $250.45 $56 $61.25 $104.65
Low 52 $0.55 $71.55 $171.41 $56 $22.99 $67.98
Price vs. 52 Week High 0.07 % -10.38 % -15.81 % 0 % -17.11 % -0.99 %
Price vs. 52 Week Low 0.07 % 17.58 % 23.01 % 0 % 120.84 % 52.41 %
Total Return
BBLN GEHC VEEV GEHCV DOCS HQY
1 Month Return 0 % 3.74 % -7.83 % 0 % -2.63 % 8.36 %
3 Month Return 0 % -7.25 % 0.41 % 0 % 15.75 % 23.6 %
6 Month Return 0 % 4.91 % 13.52 % 0 % 78.39 % 34.45 %
9 Month Return 0 % -2.32 % 4.58 % 0 % 99.72 % 29.14 %
YTD Return 0 % 7.61 % 0.29 % 0 % -4.91 % 7.98 %
1 Year Return 0 % 10.45 % 1.04 % 0 % 71.87 % 43.13 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BBLN GEHC VEEV GEHCV DOCS HQY
Dividend Yield Percentage (TTM) - 0.18 % - 0.18 % - -
Dividend Paid and Capex Coverage Ration (TTM) -37.08 % 4.67 % 55.98 % 4.67 % 76.15 % 0.68 %
Dividend Per Share (TTM) - 0.16 % - 0.16 % - -
Payout Ratio (TTM) - 3.22 % - 3.22 % - -
Growth
BBLN GEHC VEEV GEHCV DOCS HQY
Asset Growth -44.89 % 17.85 % 23.03 % 17.85 % -5.06 % 2.42 %
Gross Profit Growth -108.54 % 10.35 % 9.1 % 10.35 % 16.19 % 27.05 %
Revenue Growth 245.88 % 6.6 % 9.68 % 6.6 % 13.45 % 16 %
Revenue 3 Year 34748.47 % 13.84 % 51.42 % 13.84 % 119.55 % 18.22 %
Revenue 5 Year 34748.47 % 17.47 % 166.6 % 17.47 % 400.08 % 151.49 %
Revenue 10 Year 34748.47 % 17.47 % 624.81 % 17.47 % 400.08 % 6.45 %
EBIT Growth -297.2 % -3.45 % -6.48 % -3.45 % 30.99 % 229.19 %
Net Income Growth -186.08 % -18.16 % 7.79 % -18.16 % 30.81 % 313.1 %
Net Income 3 Yeari Growth Per Share -694.86 % -23.86 % 29.84 % -23.86 % 180.84 % 447.15 %
Net Income 5 Yeari Growth Per Share -694.86 % 2.82 % 122.44 % 2.82 % 1598.33 % -45.52 %
Net Income 10 Yeari Growth Per Share -694.86 % 2.82 % 1334.57 % 2.82 % 1598.33 % 198.41 %
Operating Income Growth -297.2 % -3.45 % -6.48 % -3.45 % 30.99 % 229.19 %
Operating Cash Flow Growth (CFG) -66.62 % -0.57 % 16.77 % -0.57 % 2.5 % 61.19 %
Operating 3 Year CFG -1006.78 % 24.46 % 55.16 % 24.46 % 111.99 % 16 %
Operating 5 Year CFG -1006.78 % 5.56 % 185.13 % 5.56 % 984.18 % 54.72 %
Operating 10 Year CFG -1006.78 % 5.56 % 1306.57 % 5.56 % 984.18 % -10.98 %
EPS Growth 93.07 % -27.96 % 4.14 % -27.96 % 34.48 % 309.68 %
EPS Diluted Growth 93.07 % -28.44 % 7.33 % -28.44 % 35.85 % 306.45 %
Book Value Per Share 96.16 % -22.1 % 20.98 % -22.1 % -5.23 % 5.94 %
Share Holder 3 Year Equity Growth Per Share -841.41 % -51.6 % 92.35 % -51.6 % 1190.4 % 28.06 %
Share Holder 5 Year Equity Growth Per Share -841.41 % - 264.94 % - 1575.37 % 208.27 %
Share Holder 10 Year Equity Growth Per Share -841.41 % - 968.64 % - 1575.37 % 295.2 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -100 %
Debt Growth 63.82 % 19.57 % -8.53 % 19.57 % -6.98 % -6.17 %
Free Cash Flow Growth -64.1 % -4.94 % 13.77 % -4.94 % 2.81 % 524.15 %
Updated On 31 Dec 2022 31 Dec 2023 31 Jan 2024 31 Dec 2023 31 Mar 2024 31 Jan 2024
Profitability
BBLN GEHC VEEV GEHCV DOCS HQY
Gross Profit Margin TTM -1.61 % 41.3 % 73.79 % 41.3 % 89.94 % 58.4 %
Return on Assets TTM -89.98 % 4.95 % 10.32 % 4.95 % 15.57 % 2.77 %
Return on Equity TTM 106.14 % 21.87 % 13.17 % 21.87 % 19.13 % 4.6 %
Return on Capital Employed TTM -441.64 % 10.2 % 11.41 % 10.2 % 20.26 % 4.96 %
Net Income Per EBT TTM 99.97 % 71.11 % 77.71 % 71.11 % 76.93 % 83.51 %
EBT Per Ebit TTM 59.91 % 91.75 % 134.26 % 91.75 % 113.28 % 70.06 %
EBIT Per Revenue TTM -33.32 % 13.14 % 24.03 % 13.14 % 38.66 % 14.37 %
Cash Flow To Debt Ratio TTM -106.22 % 19.45 % 1503.85 % 19.45 % 1669.74 % 630.07 %
Receivables Turnover TTM 36.2 4.65 8.82 4.65 4.14 10.78
Payables Turnover TTM 117.45 3.94 21.86 3.94 18.77 46.23
Inventory Turnover TTM -3758.41 5.41 - 5.41 - -
Fixed Asset Turnover TTM 4270.42 % 770.3 % 2289.56 % 770.3 % 2287.75 % 2360.41 %
Asset Turnover TTM 450.88 % 57.77 % 41.17 % 57.77 % 46.21 % 32.98 %
Operating Cash Flow Per Share TTM -17.12 4.57 6.66 4.57 1.21 3.91
Free Cash Flow Per Share TTM -17.58 3.71 6.54 3.71 1.19 -1.86
Cash Per Share TTM 235.78 % 776.81 % 3125.55 % 776.81 % 432.51 % 369.48 %
Operating Cash Flow Sales Ratio TTM -28.45 % 10.68 % 40.59 % 10.68 % 43.58 % 29.66 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.7 % 81.18 % 98.21 % 81.18 % 98.69 % -47.48 %
Cash Flow Coverage Ratios TTM -106.22 % 19.45 % 1503.85 % 19.45 % 1669.74 % 630.07 %
Price To Free Cash Flows Ratio TTM - 22.75 32.33 22.75 42.64 -55.43
Price To Operating Cash Flows Ratio TTM - 18.47 31.68 18.47 41.98 26.48
Price Cash Flow Ratio TTM - 18.47 31.68 18.47 41.98 26.48
Income Statement (TTM)
BBLN GEHC VEEV GEHCV DOCS HQY
Revenue $1.11B $19.55B $2.36B $19.55B $0.48B $1B
Gross Profit $0.01B $7.92B $1.69B $7.92B $0.42B $0.62B
Gross Profit Ratio 1.09% 40.52% 71.35% 40.52% 89.34% 62.29%
EBITDA $-0.32B $3.51B $0.46B $3.51B $0.18B $0.28B
Net Income $-0.22B $1.57B $0.53B $1.57B $0.15B $0.06B
EPS Diluted -12.01 3.02 3.22 3.02 0.72 0.64
Balance Sheet (MRQ)
BBLN GEHC VEEV GEHCV DOCS HQY
Long Term Debt $0.29B $8.75B $0.05B $8.75B $0.01B $0.92B
Total Liabilities $0.5B $25.14B $1.27B $25.14B $0.18B $1.13B
Total Equity $-0.26B $7.31B $4.64B $7.31B $0.9B $2.04B
Total Investments $0B $0.36B $3.32B $0.36B $0.67B $0.84B
Total Debt $0.3B $9.86B $0.06B $9.86B $0.01B $0.93B
Total Assets $0.25B $32.45B $5.91B $32.45B $1.08B $3.16B
Cash Flow Statement (TTM)
BBLN GEHC VEEV GEHCV DOCS HQY
Net Income $-0.22B $1.57B $0.53B $1.57B $0.15B $0.06B
Inventory $0B $0.11B $0B $0.11B $0B $0B
Dividends Paid $0B $-0.04B $0B $-0.04B $0B $0B
Operating Cash Flow $-0.31B $2.1B $0.91B $2.1B $0.18B $0.24B
Capital Expenditure $-0.01B $-0.39B $-0.03B $-0.39B $-0.01B $-0.05B
Related Stocks
Ticker Name Price
ACCD Accolade, Inc. 6.865
ACON Aclarion, Inc. 0.039
ACONW Aclarion, Inc. 0.0359
AGTI Agiliti, Inc. 10.05
AKLI Akili, Inc. 0.4331
AMWL American Well Corporation 8.3
AUGX Augmedix, Inc. 2.345
BEAT HeartBeam, Inc. 2.12
BEATW HeartBeam, Inc. 0.4502
BFRG Bullfrog AI Holdings, Inc. Common Stock 2.1439
BFRGW Bullfrog AI Holdings, Inc. Warrants 0.5447
BTSG BrightSpring Health Services, Inc. Common Stock 18.05
BTSGU BrightSpring Health Services, Inc. Tangible Equity Unit 65.82
CCLD CareCloud, Inc. 2.845
CCLDO CareCloud, Inc. 18.652
CCLDP CareCloud, Inc. 19.17
CERN Cerner Corporation 94.92
CERT Certara, Inc. 11.75
CHNG Change Healthcare Inc. 27.49
CHNGU Change Healthcare Inc. 73.71
ETFs With Exposure to BBLN
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0 225.13
IWO iShares Russell 2000 Growth ETF 0 293.99
HDG ProShares Hedge Replication ETF 0 49.297
UWM ProShares Ultra Russell2000 0 43.3
IWC iShares Micro-Cap ETF 0.01 129.106
URTY ProShares UltraPro Russell2000 0 51.5801
KOMP SPDR S&P Kensho New Economies Composite ETF 0.01 52.11
RYLD Global X Russell 2000 Covered Call ETF 0 16.665
SPAK Defiance Next Gen SPAC Derived ETF 0.09 14.63
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
SWSSX Schwab Small-Cap Index Fund-Select Shares 0 35.55
Unlock